Gabather AB (publ)

Research Gabather AB (publ) (GABA) on Bullrun: market cap SEK 23.32M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGABA
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencySEK
• Market capSEK 23.32M
• Financial periodQ4 2025
• Net income-SEK 1.33M
• Free cash flow-SEK 2.36M

Valuation Snapshot

latest market cap is SEK 23.32M.

About Gabather AB (publ)

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer's disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment of Alzheimer's disease, schizophrenia, and major depressive disorders.

Frequently asked questions

What is Gabather AB (publ)'s market cap?

Gabather AB (publ)'s market capitalization is SEK 23.32M.

What does Gabather AB (publ) do?

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases.